Cerebrolysin for speech recovery after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke for the first time that affected the left side of your brain.
- You have trouble speaking fluently (non-fluent aphasia), confirmed by a language test.
- You are a native Korean speaker between 19 and 90 years old.
- You are right-handed.
- You are within one month of your stroke.
- You are not allergic to Cerebrolysin and do not have serious other health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies different doses of a targeted brain stimulation technique to treat aphasia (language problems) after a first stroke. If you qualify, the goal is to see whether the treatment can improve your ability to understand and speak.
This trial studies a targeted, non-surgical brain stimulation approach to improve aphasia (language problems) after a first stroke. It may help people regain better language skills by guiding stimulation to specific brain areas.
This trial tests a focused brain stimulation approach (cTBS) guided by a planning method (pBFS) to improve language problems after stroke. If you have new stroke-related aphasia, it may help your ability to understand and produce speech as you recover.
This study tests whether stimulating the cerebellum can improve word-finding and language skills in people with aphasia after a left-sided stroke. It’s meant for people who are months past their stroke and still have naming difficulties.
This study looks at how the brain rewires itself after a stroke that causes aphasia (language problems). It uses brain scans to understand changes in brain networks, which may help improve recovery treatments.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.